Bristol Myers Squibb Co (BMY)

Healthcare

$61.46

LAST CLOSE · OCT 1

Bristol Myers Squibb Co (BMY) is a Healthcare stock tracked by StreetAlpha. It last closed at $61.46 on Oct 1. BMY reports earnings on Thu, Oct 29, 2026. The average 12-month price target from 11 analysts is $69.45 (+13.0% from the last close), with a high of $82.00 and a low of $59.00. Analyst consensus is Buy, based on the latest ratings from 11 firms (6 buy, 5 hold, 0 sell). Over the past 90 days StreetAlpha recorded 7 whale options trades in BMY, 57% of them bullish and 43% bearish. In the past 30 days there were 11 dark pool prints totaling $10.9M, the largest $2.2M.

FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily Cboe FLEX report for unusually large, long-dated positions.

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BMY is in one of them and how their past BMY trades turned out.

StreetAlpha hasn't covered BMY in an article yet. Here's the latest on the wider market.